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Specific nongenomic actions of aldosterone. steroid hormones can elicit rapid, nongenomic effects
Background. According to the traditional model, steroid that are incompatible with genomic mechanisms of ste-
hormones modulate gene transcription and protein synthesis. roid action. Nongenomic steroid action is mainly charac-The considerable latency of these genomic steroid effects is
terized by its rapid onset and its insensitivity towardthe consequence of these time-consuming steps of action. Over
actinomycin D and cycloheximide. Evidence for nonge-the years, it has become increasingly clear that rapid actions of
steroids exist that are incompatible with this “classic” genomic nomic steroid effects has been provided for all classes
model of action. These rapid, nongenomic effects, which re- of steroid hormones, including the secosteroid vitamin
cently have been shown for virtually all groups of steroids, are
D3 and triiodothyronine [3, 4]. In the context of nongeno-likely to be transmitted by specific membrane receptors.
mic steroid action, specific binding sites for various ste-Methods. A review of data mainly focusing on the nongeno-
mic in vitro and in vivo effects of aldosterone is presented. roids have been described in cellular membranes,
Results. For rapid aldosterone effects, a prominent example exposing pharmacological properties distinct from those
of a receptor/effector cascade for nongenomic steroid effects of the classic intracellular receptors [3]. Examples ofhas been described in various cell types. Nonclassic membrane
rapid nongenomic steroid action include the rapid stimu-receptors with a high affinity for aldosterone, but not for cortisol,
lation of ion fluxes and the acrosome reaction in humanseem to be involved. As an important second messenger, [Ca21]i
is consistently increased within minutes after the addition of sperm by progesterone [5, 6], as well as the modulation
aldosterone. The effects are half maximal at physiological con- of Ca21 fluxes induced by testosterone [7, 8] and vitamin
centrations of free aldosterone (approximately 0.1 nmol/L),
D3 [9]. The rapid, nongenomic actions of the mineralo-while the classic mineralocorticoid antagonist canrenone is in-
corticoid aldosterone are specified in this article.effective in blocking the action of aldosterone. In addition,
cortisol is active only at supramicromolar concentrations. Aldo-
sterone rapidly acts on further cell signaling systems, for exam-
HISTORYple, phosphoinositide hydrolysis and cAMP generation.
Conclusions. For a better understanding of nongenomic al- The first data on the rapid nongenomic effects of aldo-
dosterone action even in a clinical context, future research will
sterone were reported about 35 years ago. Spach andhave to target the cloning of the first membrane receptor for
Streeten demonstrated in vitro effects of aldosterone onaldosterone and the evaluation of the clinical relevance of rapid
steroid effects in general. sodium exchange in dog erythrocytes at physiological
aldosterone concentrations [10]. Because of the lack of
a nucleus, in vitro effects in these cells cannot be genomic
Traditionally, steroid hormone action has been de- in nature and therefore must be nongenomic ones. The
scribed as the modulation of nuclear transcription, thus first acute cardiovascular effects of aldosterone in hu-
triggering genomic events that are responsible for physi- mans were reported by Klein and Henk [11]. Increased
ological effects [1]. Steroid hormones influence gene peripheral vascular resistance and blood pressure and
transcription via interaction with intracellular receptors decreased cardiac output were measured within five min-
that are considered to represent a protein superfamily utes after the administration of aldosterone (0.5 mg intra-
because of homologies in their molecular structure [2]. venously), suggesting a nongenomic mechanism of action
Being sensitive to inhibitors of transcription and transla- because of the short time frame. Despite these early
tion, for example, actinomycin D and cycloheximide, observations, research on the mechanisms for nongeno-
related and delayed physiological responses are classified mic actions of aldosterone is relatively recent [12, 13].
as genomic actions of steroids.
During the past two decades, it has been shown that
IN VITRO EFFECTS OF ALDOSTERONE
Further investigations on rapid aldosterone action,Key words: aldosterone, cell signaling, gene transcription, steroid hor-
mones. triggered by observations on [3H]aldosterone binding to
lymphocytes [14], were done with regard to electrolyteÓ 2000 by the International Society of Nephrology
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transport, including changes of intracellular electrolytes, reached a plateau within two to three minutes. Consis-
cell volume, and an activation of the sodium-proton ex- tent with the results described previously in this article,
changer of the cell membrane. These studies on time in VSMCs, the EC50 for aldosterone was approximately
course, pharmacology, and the membrane receptors and 0.1 nmol/L, while cortisol and other glucocorticoids were
second messengers potentially involved were done in active at or above micromolar concentrations only. The
human mononuclear leukocytes (HMLs), vascular smooth aldosterone antagonist spironolactone (10 mmol/L) did
muscle cells (VSMCs), and porcine aortic endothelial not antagonize the effect of aldosterone [22, 23]. These
cells (PAECs). results are in line with studies by Doolan and Harvey,
In HMLs, aldosterone significantly increased intracel- who investigated rapid aldosterone-induced effects on
lular Ca21 ([Ca21]i), potassium, sodium, and the cell vol- [Ca21]i of rat distal colon [24].
ume within one hour, thus in a time range in which Since the mentioned EC50 of approximately 0.1 nmol/L
genomic actions cannot be ruled out. Half-maximal ef- is similar to the concentration of free aldosterone in
fects were demonstrated at approximately 0.1 nmol/L human serum [25], a physiological role of the rapid aldo-
aldosterone [13, 15, 16]. However, very rapid aldosterone sterone-induced effects may be hypothesized, as they
effects have also been shown in these cells. For example, neither require concentrations, which are too high to
an aldosterone-induced activation of the sodium-proton occur under physiological conditions, nor would they be
exchanger was determined, which was significant after expected to be completely active under these conditions.
only one to two minutes of incubation. The EC50 of this Depletion of [Ca21]i stores by thapsigargin blocked
effect was also in the subnanomolar range. Cortisol and the aldosterone-dependent release of Ca21. In Ca21-free
other glucocorticoids were active at supramicromolar medium, the initial rise of Ca21 seen after aldosterone
concentrations only, suggesting the involvement of a stimulation was still visible, whereas the plateau had
novel receptor, as the classic intracellular aldosterone vanished. Apparently, this nongenomic steroid effect in-
receptor binds mineralocorticoids and glucocorticoids volves an initial release of Ca21 from intracellular stores,
with similar affinities. Moreover, the type I mineralocor- followed by an influx of extracellular Ca21. However,
ticoid receptor antagonist canrenone as well as actinomy- between various cell types, both contributions seem to
cin D and cycloheximide did not block these effects [17]. differ in their relative significance. The release of Ca21
In VSMCs, a similar effect of aldosterone on the so- from intracellular stores was found to be the predomi-
dium proton exchanger was found with an apparent EC50 nant effect in VSMCs. In PAECs, Ca21 influx is more
of about 0.2 nmol/L. Similar to the studies in HMLs, prominent, as shown by single-cell imaging and the more
cortisol was ineffective at micromolar concentrations, pronounced blunting effect of removal of the external
and canrenone did not block aldosterone effects at 1000-
Ca21 [22]. In addition, in latter cells, the EC50 value offold excess concentrations [18].
aldosterone is lower than in VSMCs by two orders ofIn further studies, nongenomic aldosterone action on
magnitude [26].cell signaling systems with respect to phosphoinositide
In contrast to the Ca21 effects induced by peptidehydrolysis [production of inositol-1,4,5-trisphosphate
agonists such as thrombin or angiotensin II, rapid nonge-(IP3) and diacylglycerol (DAG)] was investigated in both nomic aldosterone action on [Ca21]i is rather small inHMLs and VSMCs. In these cells, aldosterone, as well
VSMCs and PAECs. Therefore, this mechanism appearsas the synthetic mineralocorticoid fludrocortisone, sig-
to be the first known “low ceiling” effector with an inher-nificantly stimulated the generation of IP3 within 30 sec-
ent safety margin, and may be useful as an instrumentonds at an EC50 of approximately 0.1 nmol/L. Dexameth-
to fine tune cardiovascular reactions. This potential roleasone and cortisol were weak agonists, showing EC50
in cardiovascular regulation is further supported by datavalues in the supramicromolar range. As demonstrated
on Ca21 increase in VSMCs induced by angiotensin II,for activation of the sodium-proton exchanger, canren-
which, after a short preincubation with aldosterone, isone did not antagonize these effects at 100-fold excess
active at 100-fold lower concentrations [23].concentrations [18, 19].
Inhibitors of tyrosine kinase and phospholipase CLike IP3, DAG production was increased in VSMCs
block rapid aldosterone effects on free [Ca21]i. Whilewithin 30 seconds by subnanomolar concentrations of
short-term treatment with phorbol esters blocked aldo-aldosterone, but only by supramicromolar concentra-
sterone effects on [Ca21]i, the protein kinase C inhibitortions of cortisol [20].
staursporine increased these effects, indicating anAs IP3 releases Ca21 from intracellular IP3-sensitive
involvement of protein kinase C in rapid aldosteronestores [21], the effects of aldosterone on free [Ca21]i were
signaling. In VSMCs, the nongenomic effects of aldoste-investigated in VSMCs and PAECs by single-cell, dual-
rone on protein kinase C a have also been directly dem-wavelength fluorometry and cell imaging employing
onstrated by immunostaining. Aldosterone rapidly in-Fura2 fluorescence [22, 23]. After the addition of aldoste-
rone, an immediate increase of Ca21 was seen, which duces a translocation of protein kinase C a isoform from
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cytosol to plasma membrane [20], an effect that is consid- [32]. The data on rapid aldosterone action and poten-
ered to be correlated with protein kinase C activation. tially related binding sites are incompatible with an
Triggered by the data on rapid aldosterone action on involvement of classic intracellular type I mineralocorti-
[Ca21]i and phosphoinositide hydrolysis in VSMCs, the coid receptors, which do not discriminate aldosterone
nongenomic effects of the steroid on intracellular cAMP and cortisol and bind canrenone with a similar affinity.
levels were recently investigated [27]. In porcine coro- To characterize these aldosterone membrane binding
nary VSMCs (PCVSMCs), an aldosterone-induced in- sites further, microsomal preparations from porcine liver
crease of intracellular cAMP levels by approximately membranes were used that showed a maximum binding
1.5- to 2.5-fold was measured within one minute. The capacity of approximately 700 fmol mg21 microsomal
EC50 of this effects was approximately 0.01 to 0.1 nmol/L. protein [29]. Binding of [3H]aldosterone was saturable,
A 15-minute preincubation of cells with spironolactone and Scatchard analysis revealed two apparent dissocia-
(10 mmol/L) did not significantly blunt this effect. This tion constants of ,11 nmol/L and 118 nmol/L, respec-
effect was not blocked by inhibitors of transcription or tively. A further purification of the aldosterone binding
protein synthesis and was found to be Ca21 dependent. sites was unsuccessful because of the instability of the
17b-estradiol and hydrocortisone act at only supraphysi- protein in its solubilized form. However, a progesterone-
ological concentrations (10 mmol/L). membrane binding protein from porcine liver micro-
Moreover, aldosterone-induced phosphorylation of somes has been characterized and cloned, which is likely
CRE binding protein (CREB) was investigated because to represent the first steroid membrane receptor, or a
it may link cAMP levels to transcription. Stimulation of part of it [33, 34].
PCVSMCs with aldosterone increased immunodetect-
able phosphorylation of CREB within minutes, whereas
the addition of the solvent alone did not significantly IN VIVO EFFECTS OF ALDOSTERONE
influence CREB phosphorylation [27]. In recent years, there has been a significant increase
of reports on the rapid in vivo actions of steroids. Particu-
larly, the rapid nongenomic effects of estradiol on vaso-MEMBRANE BINDING SITES
regulation have gained extensive interest because of theirFOR ALDOSTERONE
possible clinical relevance in hormone replacement ther-The rapid time course, along with the unique pharma-
apy during menopause.cological properties of the nongenomic action of aldoste-
Convincing in vivo evidence has been described forrone and other steroids, is not covered by the classic
rapid aldosterone action, including effects on the barore-genomic concept of steroid action. Therefore, nongeno-
ceptor neuron discharge frequency in the dog, whichmic steroid effects are supposed to act via different path-
occur as early as 15 minutes after the application ofways, including receptors distinctly different from those
the steroid [35]. In addition, aldosterone was found toinvolved in genomic steroid actions.
significantly increase peripheral vascular resistance andSteroid membrane-binding sites have been described
blood pressure in humans, while cardiac output was de-and partly characterized in various tissues and are thought
creased within five minutes after an injection of aldoste-to be receptor candidates for rapid steroid signaling [3].
rone [11]. The results of the latter study have been con-In particular, binding sites for aldosterone have been
firmed in catheterization studies by using modernfound in HMLs, pig liver, and kidney by the use of radio-
invasive techniques. Systemic vascular resistance was sig-actively labeled aldosterone analogues [28–30].
nificantly increased after an intravenous application ofIn binding studies with microsomes of porcine kidney
0.5 mg aldosterone within three minutes [36]. Furtherand HMLs, specific saturable binding was demonstrated
clinical significance for rapid aldosterone action wasat a kD of approximately 0.1 nmol/L for the radioligand;
found in a study in which calf phosphocreatine concen-displacement experiments showed a kD of approximately
trations were monitored by nuclear magnetic resonance0.1 nmol/L for aldosterone [28, 30]. Canrenone and corti-
sol were inactive as ligands up to micromolar concentra- spectroscopy at rest and under stress [37]. Aldosterone
tions, whereas fludrocortisone and desoxycorticosterone (0.5 mg intravenously) significantly facilitated phospho-
acetate had an intermediate activity. creatine recovery after stress, an effect starting within
As aldosterone-binding characteristics, with regard to eight minutes after the application of the steroid.
important kinetic and pharmacological properties, are
in perfect agreement with the functional data of rapid
INTEGRATIVE MODEL OFaldosterone effects mentioned previously in this article,
ALDOSTERONE ACTIONthese binding sites therefore may mediate rapid aldoste-
Taking all of the findings demonstrated previously inrone action. These results are also in line with those re-
ported for cultured kidney cells [31] and distal rat colon this article together, it becomes clear that the classic
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Fig. 1. The integrative two-step model for mineralocorticoid action. In addition to the scheme representing the classic genomic theory of
mineralocorticoid action (left), the rapid pathway is shown (right), summarizing observations on rapid effects of aldosterone on the sodium-proton
exchanger (Na1/H1 antiporter), intracellular second messengers (IPYK, intermediate tyrosine kinase; IP3, inositol-1,4,5-trisphosphate; DAG,
diacylglycerol; [Ca21]i, free intracellular calcium; PKC, protein kinase C), and aldosterone binding to membrane receptors (reprinted from Christ
and Wehling [38], used with permission of Cardiovasc Res).
genomic model does not adequately cover all aspects of CONCLUSION
steroid action. Therefore, a two-step model of steroid In addition to the multitude of nongenomic aldoste-
action has been recently proposed (Fig. 1) [3, 38]. Al- rone effects described during the past two decades, the
though originally developed for mineralocorticoids, it identification, characterization, and cloning of the first
appears to be applicable to most steroids. On the one aldosterone membrane receptor remain the major goals.
hand, the model describes nongenomic steroid action Thereafter, researchers will be able to efficiently gener-
that comprises binding to membrane receptors followed ate specific agonists and antagonists for the further char-
by cellular signaling. On the other hand, genomic steroid acterization of the relevance of nongenomic steroid ac-
actions are enclosed that involve steroid binding to intra- tion with regard to physiology and pathophysiology.
cellular receptors, resulting in the modulation of tran- Development of new therapeutic compounds that are
scription. Moreover, as a yet unproved hypothesis, the able to inhibit rapid steroid actions, or even both the
interaction of both pathways is included in the model nongenomic and genomic effects, could yield therapeutic
because there is increasing evidence for second messen- benefits in a variety of clinical fields, including cardiovas-
ger-related modulation of steroid-induced transcrip- cular, obstetric, and endocrinologic disorders.
tional processes [39, 40]. Steroid hormones may act
Reprint requests to Martin Wehling, M.D., Institute of Clinical Phar-through both mechanisms simultaneously, and these
macology, Faculty of Clinical Medicine Mannheim, University of Hei-
mechanisms appear to be important co-mediators in the delberg, Theodor-Kutzer-Ufer, 68135 Mannheim, Germany.
E-mail: martin.wehling@kpha.ma.uni-heidelberg.dewide range of cellular steroid effects.
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